<!doctype html>
<html lang="en">
<head>
<meta charset="utf-8">
<title>Annotated example</title>
<style>
body {
  font-family: ui-sans-serif, -apple-system, Segoe UI, Roboto, Helvetica, Arial, "Apple Color Emoji", "Segoe UI Emoji";
  margin: 24px;
  color: #111827;
  background: #ffffff;
}
.container {
  max-width: 920px;
  margin: 0 auto;
}
.header {
  margin-bottom: 20px;
}
.subtle {
  color: #6b7280;
  font-size: 14px;
}
.message {
  white-space: pre-wrap;
  line-height: 1.6;
  font-size: 16px;
  background: #fafafa;
  border: 1px solid #e5e7eb;
  border-radius: 8px;
  padding: 16px;
}
.legend {
  display: flex;
  gap: 12px;
  flex-wrap: wrap;
  margin: 12px 0 20px 0;
}
.legend-item {
  display: inline-flex;
  align-items: center;
  gap: 8px;
  font-size: 14px;
}
.badge {
  display: inline-block;
  border-radius: 6px;
  padding: 4px 8px;
  border: 1px solid #d1d5db;
  background: #f3f4f6;
  color: #374151;
  font-weight: 600;
}
.ann {
  border-radius: 4px;
  padding: 0 2px;
  border-width: 1px;
  border-style: solid;
}
.sidebar {
  margin-top: 24px;
  border-top: 1px solid #e5e7eb;
  padding-top: 12px;
}
.sidebar h3 {
  margin: 8px 0;
  font-size: 16px;
}
.sidebar .ann-item {
  margin-bottom: 10px;
  font-size: 14px;
}
blockquote {
  margin: 0 0 12px 0;
  border-left: 3px solid #d1d5db;
  padding-left: 12px;
  color: #4b5563;
}
a {
  color: #2563eb;
  text-decoration: none;
}
a:hover {
  text-decoration: underline;
}
.footer {
  margin-top: 24px;
  font-size: 12px;
  color: #6b7280;
}
</style>
</head>
<body>
<div class="container">
  <div class="header">
    <h2>Annotated Assistant Response</h2>
    <div class="legend"><span class="legend-item"><span class="badge" style="background:#e6ffed;border-color:#34d058;color:#22863a">Supported</span></span><span class="legend-item"><span class="badge" style="background:#ffeef0;border-color:#f85149;color:#b31d28">Not Supported</span></span><span class="legend-item"><span class="badge" style="background:#fff5e5;border-color:#f2a654;color:#9a6700">Insufficient Information</span></span></div>
    <div class="subtle"><strong>pubmedqa_id:</strong> 23806388</div>
<div class="subtle"><strong>original_answer:</strong> yes</div>
<div class="subtle"><strong>context:</strong> To examine the ability of various postoperative nomograms to predict prostate cancer-specific mortality (PCSM) and to validate that they could predict aggressive biochemical recurrence (BCR). Prostate-specific antigen (PSA), grade, and stage are the classic triad used to predict BCR after radical prostatectomy (RP). Multiple nomograms use these to predict risk of BCR. A previous study showed that several nomograms could predict aggressive BCR (prostate-specific antigen doubling time [PSADT] &lt;9 months) more accurately than BCR. However, it remains unknown if they can predict more definitive endpoints, such as PCSM. We performed Cox analyses to examine the ability of 4 postoperative nomograms, the Duke Prostate Center (DPC) nomogram, the Kattan postoperative nomogram, the Johns Hopkins Hospital (JHH) nomogram, and the joint Center for Prostate Disease Research(CPDR)/Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) nomogram to predict BCR and PCSM among 1778 men in th</div>
<div class="subtle"><strong>source:</strong> pubmedqa_meditron</div>
<div class="subtle"><strong>user_prompt:</strong> Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR?</div>
  </div>
  <div class="message">yes
Explanation: <span class="ann" title="Supported: Study: &#x27;Do Nomograms Designed to Predict Biochemical Recurrence (BCR) Do a Better Job of Predicting More Clinically Relevant Prostate Cancer Outcomes than BCR?&#x27; found that four nomograms (DPC, Kattan postoperative, JHH, CPDR/CaPSURE) designed to predict BCR after radical prostatectomy predicted prostate cancer-specific mortality (PCSM) and aggressive BCR more accurately than BCR itself. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3774016/?utm_source=openai))" style="background:#e6ffed;border-color:#34d058;color:#22863a;">Nomograms designed to predict BCR after RP can predict more clinically relevant prostate cancer outcomes than BCR</span>. <span class="ann" title="Insufficient Information: I found no clear evidence in the literature reviewed that nomograms designed for predicting BCR after radical prostatectomy have been shown to predict outcomes in patients undergoing active surveillance." style="background:#fff5e5;border-color:#f2a654;color:#9a6700;">This suggests that these nomograms may have the potential to predict outcomes after active surveillance (AS)</span>. <span class="ann" title="Not Supported: Contradicted by studies: there are nomograms validated for use in active surveillance-for example, a nomogram predicting pathologic upgrade in AS patients (Keimyung / Kyungpook cohort, 2010-2016, etc.) was developed and externally validated. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31913073/?utm_source=openai))" style="background:#ffeef0;border-color:#f85149;color:#b31d28;">To date, no nomogram has been validated to predict outcomes after AS</span>.</div>
  <div class="sidebar"><h3>Placed annotations</h3><div class="ann-item"><span class="badge" style="background:#e6ffed;border-color:#34d058;color:#22863a">Supported</span> <strong>Nomograms designed to predict BCR after RP can predict more clinically relevant prostate cancer outcomes than BCR</strong> (idx 17) — Study: &#x27;Do Nomograms Designed to Predict Biochemical Recurrence (BCR) Do a Better Job of Predicting More Clinically Relevant Prostate Cancer Outcomes than BCR?&#x27; found that four nomograms (DPC, Kattan postoperative, JHH, CPDR/CaPSURE) designed to predict BCR after radical prostatectomy predicted prostate cancer-specific mortality (PCSM) and aggressive BCR more accurately than BCR itself. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3774016/?utm_source=openai))</div><div class="ann-item"><span class="badge" style="background:#fff5e5;border-color:#f2a654;color:#9a6700">Insufficient Information</span> <strong>This suggests that these nomograms may have the potential to predict outcomes after active surveillance (AS)</strong> (idx 132) — I found no clear evidence in the literature reviewed that nomograms designed for predicting BCR after radical prostatectomy have been shown to predict outcomes in patients undergoing active surveillance.</div><div class="ann-item"><span class="badge" style="background:#ffeef0;border-color:#f85149;color:#b31d28">Not Supported</span> <strong>To date, no nomogram has been validated to predict outcomes after AS</strong> (idx 242) — Contradicted by studies: there are nomograms validated for use in active surveillance-for example, a nomogram predicting pathologic upgrade in AS patients (Keimyung / Kyungpook cohort, 2010-2016, etc.) was developed and externally validated. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31913073/?utm_source=openai))</div></div>
  
  <div class="footer">Generated by annotate_from_spans.py</div>
</div>
</body>
</html>